Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

18.8K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
18.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Report: Tumor regression and neurological recovery in paraplegia from POLD1-mutated hepatocellular carcinoma treated with targeted immunotherapy and electroacupuncture.

Frontiers in immunology·2026
Same author

Nimotuzumab combined with gemcitabine and nab-paclitaxel as first-line therapy for advanced pancreatic cancer: a single-arm, single-center Phase II prospective study.

Frontiers in medicine·2026
Same author

PAD4-mediated citrullination of IGF2BP2 stabilizes MCM mRNAs to drive intrahepatic cholangiocarcinoma progression.

Journal of advanced research·2026
Same author

Research Progress on Alzheimer's Disease with Classical Traditional Chinese Medicine Formulas.

Current drug delivery·2026
Same author

PDGF receptor-β-targeted copper-zinc nanozyme interfered glycolysis and remodelled tumor microenvironment for enhanced cuproptosis of lung cancer.

Colloids and surfaces. B, Biointerfaces·2026
Same author

The recent research progress on traditional Chinese medicine application in Parkinson's disease: a review.

Frontiers in aging neuroscience·2026

Related Experiment Video

Updated: Sep 24, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.7K

A Machine Learning Method to Trace Cancer Primary Lesion Using Microarray-Based Gene Expression Data.

Qingfeng Lu1, Fengxia Chen2, Qianyue Li3

  • 1Oncology Department, Daqing Oilfield General Hospital, Daqing, China.

Frontiers in Oncology
|May 9, 2022
PubMed
Summary
This summary is machine-generated.

Identifying the origin of cancer of unknown primary (CUP) is crucial for effective treatment. This study developed an efficient Extreme Gradient Boosting (XGBoost) method using gene expression data to accurately trace CUP

Keywords:
XGBoostcancer of the unknown primary sitegene expressiongene selectionhuman malignancies

More Related Videos

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.1K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.0K

Related Experiment Videos

Last Updated: Sep 24, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.7K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.1K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.0K

Area of Science:

  • Oncology
  • Bioinformatics
  • Computational Biology

Background:

  • Cancer of unknown primary (CUP) constitutes 3%-5% of all malignancies.
  • Conventional methods often fail to identify the tissue of origin for CUP.
  • Accurate primary site identification is essential for improving patient prognosis through targeted therapy.

Purpose of the Study:

  • To develop an efficient computational method for tracing the primary site of CUP.
  • To leverage microarray-based gene expression data for CUP origin identification.
  • To improve clinical cancer traceability and patient outcomes.

Main Methods:

  • Utilized Extreme Gradient Boosting (XGBoost) algorithm for primary site prediction.
  • Employed large-scale gene expression datasets from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO).
  • Trained and validated XGBoost models using a 4:1 ratio of training to independent testing data.

Main Results:

  • Achieved high 5-fold cross-validation accuracies of 96.9% (TCGA) and 95.3% (GEO).
  • Reached excellent macro-precision rates of 96.75% (TCGA) and 98.8% (GEO) on independent datasets.
  • Demonstrated the XGBoost framework's efficiency and potential for cost reduction in clinical cancer traceability.

Conclusions:

  • The developed XGBoost framework accurately identifies the primary site of CUP using gene expression data.
  • This method offers a highly efficient and potentially cost-effective tool for clinical cancer traceability.
  • The findings suggest significant utility for this approach in clinical cancer research and patient management.